{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:51:17Z","timestamp":1740167477043,"version":"3.37.3"},"reference-count":8,"publisher":"The Korean Association for the Study of the Liver","issue":"4","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["e-cmh.org"],"crossmark-restriction":true},"short-container-title":["Clin Mol Hepatol"],"published-print":{"date-parts":[[2024,10,1]]},"DOI":"10.3350\/cmh.2024.0228","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T07:46:11Z","timestamp":1712821571000},"page":"1031-1032","update-policy":"https:\/\/doi.org\/10.3350\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to correspondence on \u201cCardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide\u201d"],"prefix":"10.3350","volume":"30","author":[{"given":"Pin-Nan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-1900","authenticated-orcid":true,"given":"Ming-Lung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1902","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0123"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0115"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v15.i8.964"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2021.0314"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14218"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17765"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313832"},{"key":"ref8","first-page":"49","volume-title":"Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide","author":"Hong","year":"2024"}],"container-title":["Clinical and Molecular Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2024-0228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2024.0228","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2024-0228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:37:14Z","timestamp":1730191034000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2024.0228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.3350\/cmh.2024.0228","relation":{},"ISSN":["2287-2728","2287-285X"],"issn-type":[{"type":"print","value":"2287-2728"},{"type":"electronic","value":"2287-285X"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"2024-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-11","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}